Bavituximab, known as TRWH-783, represents a exciting immunotherapy strategy targeting phosphatidylserine (PS). PS is usually an inside lipid present on cell membranes; however, it's frequently exposed on the outer of https://shaunasjuf976623.aboutyoublog.com/profile